Louis Sloan

University of California, Los Angeles US

0009-0004-1465-7334

Publications

2,079

Citations

H-Index

i10-Index

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

31 total

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

David A. Margolis, Juan González‐García, Hans-Jürgen Stellbrink, Joseph J. Eron, Yazdan Yazdanpanah et al. - The Lancet, 2017

Cited by 501 OpenAlex

Research Topics

HIV Research and Treatment (28) HIV/AIDS drug development and treatment (19) HIV-related health complications and treatments (11) Immunotherapy and Immune Responses (10) HIV/AIDS Research and Interventions (8)

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

US 2017 - 2017

Research Triangle Park Foundation

US 2014 - 2014

Baylor University

US 2014 - 2009

University of California, Los Angeles

US 2025 - 2025

New York Medical College

US 2013 - 2013

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers

Louis Sloan

Publication & Citation Trends

Publications

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back